Affibody AB
556665-6913ActiveDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Biotechnology Companyaffibody.se
Yleiskatsaus
- 50–99
- Työntekijät
- 20–50milj SEK
- Liikevaihto
- 2004
- Perustettu
Avainpäättäjät
Peter Zerhouni
Chief Financial Officer & Chief Business Officer
+46706XXXXXX
David Bejker
Chief Executive Officer
+46706XXXXXX
Mathias Uhlén
Board Director
Anders Martin-Löf
Board Director
+11 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Affibody is a specialized biotechnology company focused on creating next-generation radiopharmaceuticals. They leverage their proprietary Affibody® platform to develop radioligand therapeutics (RLTs) designed for precision targeting. The company strategically focuses its pipeline on major cancer typ...